Dergiler / Ulusal Travma ve Acil Cerrahi Dergisi / 2021 / Cilt: 27 - Sayı: 6

Indicators that determine disease course in COVID-19 patients

COVID-19 hastalarında hastalığın seyrini belirleyen göstergeler

Sayfa
668–676
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

CONCLUSION: Comorbidity, clinical features, and laboratory findings are parameters that can help in predicting the clinical course of hospitalized patients due to COVID-19.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:BACKGROUND: In this study, it was tried to determine the factors affecting the clinical process in patients who were followed up in hospital for coronavirus disease-2019 (COVID-19).
📊
Temel Bulgular & Veri:METHODS: The study, which was designed as a single-center and retrospective cohort, included 658 patients admitted to the service due to COVID-19.
💡
Sonuç & Katkı:CONCLUSION: Comorbidity, clinical features, and laboratory findings are parameters that can help in predicting the clinical course of hospitalized patients due to COVID-19.
🔬Tür:Araştırma Makalesi
📍Kapsam:2019 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

BACKGROUND: In this study, it was tried to determine the factors affecting the clinical process in patients who were followed up in hospital for coronavirus disease-2019 (COVID-19). METHODS: The study, which was designed as a single-center and retrospective cohort, included 658 patients admitted to the service due to COVID-19. The patients were grouped and compared as the patients followed up in the wards (Group 1) and those admitted to ICU (Group 2), between those who were intubated (Group I) in the ICU and those who were not (Group NI), and between patient groups who died (Group M) and survived (Group NM) among those who were intubated. RESULTS: Of the 658 patients hospitalized in the wards, 566 (86%) were discharged and 99 (14%) were later admitted to the ICU. The mortality rate for the 658 patients that were followed up was found to be 7.75%. When Groups 1 and 2 were compared, it was observed that the patients in Group 2 had more comorbidity and higher KDIGO stages (p<0.001). In addition, patients in Group 2 had older age, higher APACHE II and SOFA scores, high WBC counts, neutrophil counts, lymphocyte counts, N/L ratio, CRP, LDH, CK, PTZ, D-dimer, procalcitonin, and ferritin values (all values p<0.001, for CK p=0.034). When the patients in Group I and Group NI were compared, it was observed that the patients in Group I had more comorbidities and higher mortality rate (p<0.001). In addition, patients in Group I had older age, high D-dimer, and ferritin levels (p=0.008; 0.011, and 0.043, respectively). When the patients in Group M and Group NM were compared, it was observed that the patients in Group M were mostly males (p=0.017) and were mostly in KDIGO Stages 1 and 2 (p=0.005). In addition, it was found that the CRP and LDH levels of patients in Group M were significantly higher than those in Group NM (p=0.018 and 0.023, respectively). CONCLUSION: Comorbidity, clinical features, and laboratory findings are parameters that can help in predicting the clinical course of hospitalized patients due to COVID-19.

Abstract

AMAÇ: Bu çalışmada, koronavirüs hastalığı-2019 nedeniyle hastanede takip edilen hastalarda klinik sürece etkili olan faktörler saptanmaya çalışıldı. GEREÇ VE YÖNTEM: Tek merkezli ve geriye dönük kohort olarak dizayn edilen çalışmaya koronavirüs hastalığı-2019 hastalığı nedeniyle servise yatan 658 hasta dahil edildi. Çalışmaya alınan hastalar öncelikle serviste takip edilenler (Grup 1) ve yoğun bakım ünitesine alınanlar (Grup 2) şeklinde; sonrasında yoğun bakım ünitesine alınan hastalar, entübe edilenler (Grup I) ve edilmeyenler (Grup NI) olarak ve son olarak entübe edilen hastalar, mortal olanlar (M) ve olmayanlar (NM) olarak gruplandırıldı ve karşılaştırıldı. BULGULAR: Çalışmaya alınan 658 hastanın 566’sı (%86) serviste takip edilip taburcu edilirken 99’u (%14) yoğun bakım ünitesine alınmıştı. Takip edilen 658 hastanın ölüm oranı %7.75 olarak bulundu. Grup 1 ve 2 karşılaştırıldığında Grup 2’deki hastaların daha fazla komorbiditeye ve daha yüksek KDIGO skorlarına sahip olduğu gözlendi (p<0.001). Ayrıca Grup 2’deki hastaların daha ileri yaş, daha yüksek APACHE II ve SOFA skorları, WBC, nötrofil, lenfosit, N/L oranı, CRP, LDH, CK, PTZ, D-dimer, prokalsitonin and ferritin değerlerine sahip olduğu gözlendi (bütün özellikler için p<0.001, CK için p=0.034). Grup I ve NI karşılaştırıldığında Grup I’daki hastaların daha fazla komorbiditeye sahip olduğu ve yüksek mortalite oranlarına sahip olduğu gözlendi (p<0.001). Ayrıca Grup I’daki hastalar daha ileri yaş, yüksek D-dimer ve ferritin düzeylerine sahipti (sırasıyla, p=0.008; 0.011 ve 0.043). Son olarak Grup M ve NM karşılaştırıldığında Grup M’deki hastaların çoğunlukla erkek (p=0.017) ve KDIGO evre 1 ve 2’deki hastalardan oluştuğu (p=0.005) gözlendi. Ayrıca Grup M’deki hastaların daha yüksek CRP ve LDH değerlerine sahip olduğu saptandı (sırasıyla, p=0.018 ve 0.023). TARTIŞMA: Komorbidite, klinik özellikler ve laboratuvar bulguları koronavirüs hastalığı-2019 nedeniyle hastaneye yatırılan hastaların klinik seyrini tahmin etmede yardımcı olabilecek parametrelerdir. Anahtar sözcükler: COVID-19; klinik özellikler; yoğun bakım ünitesi.

🔖

Bu Makaleye Atıf Yap

UZUNDERE, O., KAÇAR, C. K., AKELMA, H., GÜL, M. S., KANDEMİR, D., AKOL, Ü., YEKTAŞ, A. (2021). Indicators that determine disease course in COVID-19 patients. Ulusal Travma ve Acil Cerrahi Dergisi, Cilt: 27 - Sayı: 6, 668–676. https://ajindex.com/articles/418682

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Xie M, Chen Q. Insight into 2019 novel coronavirus-an updated interim review and lessons from SARS-CoV and MERS-CoV. Int J Infect Dis 2020;94:119–24
  2. World Health Organization Coronavirus Disease (COVID-19) Dashboard. Available from: https://www.covid19.who.int. Accessed Dec 01, 2020
  3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395:497–506
  4. Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1,590 patients with Covid-19 in China: A nationwide analysis. Eur Respir J 2020;55:2000547
  5. Yan Y, Yang Y, Wang F, Ren H, Zhang S, Shi X, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ Open Diabetes Res Care 2020;8:1343
  6. Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: Implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res 2020;116:1666–87
  7. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 2020;323:2052
  8. Clinical Management of COVID-19. Available from: https://www.who. int/publications/i/item/clinical-management-of-covid-19. Accessed Oct 25, 2020
  9. T.C. Sağlık Bakanliği COVID-19 Bilgilendirme Sayfası. Ağır Pnömoni, ARDS, Sepsis ve Septik Şok Yönetimi. Available from: https://www. mcovid19.saglik.gov.tr/TR-66340/agir-pnomoni-ards-sepsis-ve-septik- sok-yonetimi.html. Accessed Oct 25, 2020
  10. Bao C, Liu X, Zhang H, Li Y, Liu J. Coronavirus disease 2019 (COVID-19) CT findings: A systematic review and meta-analysis. J Am Coll Radiol 2020;17:701–9
  11. Hani C, Trieu NH, Saab I, Dangeard S, Bennani S, Chassagnon G, et al. COVID-19 pneumonia: A review of typical CT findings and differential diagnosis. Diagn Interv Imaging 2020;101:263–8
  12. Zou X, Li S, Fang M, Hu M, Bian Y, Ling J, et al. Acute physiology and chronic health evaluation II score as a predictor of hospital mortality in patients of coronavirus disease 2019. Crit Care Med 2020;48:E657–65
  13. Yao Q, Wang P, Wang X, Qie G, Meng M, Tong X, et al. A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients. Polish Arch Intern Med 2020;130:390–9
  14. Zhang G, Hu C, Luo L,